FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

By Annika Kim Constantino

FDA to consider drug affordability when granting new vouchers to speed up approvals, Makary says

It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually determined after an approval in the U.S.

Read More…